Cargando…
Change in Off-Label Use of Bone Morphogenetic Protein in Spine Surgery and Associations with Adverse Outcome
Study Design Retrospective cohort study. Objective The U.S. Food and Drug Administration issued a warning in 2008 against off-label bone morphogenetic protein (BMP-2) use. We aimed to determine (off-label) BMP-2 use in two periods and associations with complications. Methods We included 340,393 pati...
Autores principales: | Poeran, Jashvant, Opperer, Mathias, Rasul, Rehana, Mazumdar, Madhu, Girardi, Federico P., Hughes, Alexander P., Memtsoudis, Stavros G., Vougioukas, Vassilios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077709/ https://www.ncbi.nlm.nih.gov/pubmed/27781184 http://dx.doi.org/10.1055/s-0036-1571284 |
Ejemplares similares
-
Use of perioperative hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasty and association with adverse outcomes: a retrospective population based analysis
por: Opperer, Mathias, et al.
Publicado: (2015) -
Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety
por: Poeran, Jashvant, et al.
Publicado: (2014) -
Blood Transfusions in Total Hip and Knee Arthroplasty: An Analysis of Outcomes
por: Danninger, Thomas, et al.
Publicado: (2014) -
Recommendations for resuming elective spine surgery in the COVID-19 era
por: Wilson, Lauren A., et al.
Publicado: (2020) -
Machine Learning Approaches to Define Candidates for Ambulatory Single Level Laminectomy Surgery
por: Li, Qiyi, et al.
Publicado: (2021)